[144] PUMA BIOTECHNOLOGY INC SEC Filing

Rhea-AI Filing Summary

Kura Sushi USA, Inc. (KRUS) filed an 8-K on July 8, 2025 to notify investors that it has released its fiscal Q3 2025 earnings via a separate press release (Exhibit 99.1) and scheduled a conference call for 5:00 p.m. EDT on July 8, 2025. The filing itself does not include any revenue, EPS or other financial metrics; it simply furnishes the press release and clarifies that the information is being provided under Item 2.02 and is therefore deemed “furnished,” not “filed,” for Exchange Act liability purposes. No other material events, transactions or changes in governance are disclosed.

Insights

Financial Analyst

TL;DR: Routine 8-K furnishes earnings press release; no financial numbers provided—impact neutral.

This 8-K is administrative. It alerts the market to the availability of Q3 2025 results and the timing of the management call, but it withholds the actual figures in Exhibit 99.1, which is not included here. Because there are no disclosed metrics, investors cannot assess performance or valuation implications from this document alone. The designation of the information as “furnished” limits potential liability and is standard practice. Overall, the filing does not alter the investment thesis until the press release contents are reviewed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4374	15454.65	49638093	07/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/07/2025	Restricted Stock Vesting	Issuer			4374	07/07/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)